How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Heart Healthy Ingredients Market
- By Ingredient Type: Omega-3 Fatty Acids, Plant Sterols and Stanols, Soluble Fiber, Antioxidants, Coenzyme Q10
- By Source: Marine Sources, Plant-Based Sources, Microbial Sources, Animal-Derived Sources
- By Application: Dietary Supplements, Functional Foods and Beverages, Pharmaceuticals, Personal Care Products
- By Form: Powder, Capsules/Tablets, Liquid, Softgels, Gummies
- By End-User: Adults, Elderly, Athletes, Patients with Cardiovascular Conditions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Omega-3 Fatty Acids leads By Ingredient Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Heart Healthy Ingredients Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Ingredient Type 5
Source 4
Application 4
Form 5
End-User 4
Companies profiled
BASF SE
Cargill
Incorporated
DuPont de Nemours Inc.
Archer Daniels Midland Company (ADM)
Ingredion Incorporated
Kerry Group plc
DSM Nutritional Products
Tate & Lyle PLC
Chr. Hansen Holding A/S
Lonza Group AG
Corbion N.V.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cargill
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DuPont de Nemours Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Archer Daniels Midland Company (ADM)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Ingredion Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Kerry Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →DSM Nutritional Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tate & Lyle PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Chr. Hansen Holding A/S
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Lonza Group AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Corbion N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Glanbia plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Evonik Industries AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Prinova Group LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Nutraceutical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,715M by 2033 · 4.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Omega-3 Fatty Acids44.4
- Plant Sterols and Stanols15.1
- Soluble Fiber14.9
- Antioxidants15.2
- Coenzyme Q1010.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,129M → $1,567M · 4.2%
Europe$787.2M → $1,119M · 4.5%
Asia Pacific$718.7M → $874.9M · 2.5%
Latin America$444.9M → $660.8M · 5.1%
Middle East and Africa$342.3M → $418.3M · 2.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.042026
4.052027
4.062028
4.082029
4.092030
4.102031
4.112032
4.132033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE21.9
- Cargill21.7
- Incorporated3.0
- DuPont de Nemours Inc.8.1
- Archer Daniels Midland Company (ADM)9.0
- Ingredion Incorporated8.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Ingredient Type22.9%
Source23.7%
Application13.3%
Form15.9%
End-User24.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe24.1
- Asia Pacific18.9
- Latin America14.2
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 80 | 81 | 93 | 94 | 97 | 73 | 86 |
| Cargill | 80 | 85 | 75 | 83 | 82 | 76 | 80 |
| Incorporated | 72 | 71 | 73 | 80 | 70 | 85 | 75 |
| DuPont de Nemours Inc. | 67 | 65 | 59 | 60 | 67 | 82 | 67 |
| Archer Daniels Midland Company (ADM) | 62 | 67 | 70 | 65 | 65 | 76 | 68 |
| Ingredion Incorporated | 47 | 54 | 66 | 68 | 68 | 68 | 62 |
| Kerry Group plc | 50 | 51 | 42 | 52 | 60 | 55 | 52 |
| DSM Nutritional Products | 43 | 39 | 39 | 55 | 35 | 56 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Cargill
- Incorporated
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Cargill | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Incorporated | ✓ | ✓ | ✓ | ✓ | − | ◐ |
| DuPont de Nemours Inc. | − | − | ◐ | ◐ | ◐ | ✓ |
| Archer Daniels Midland Company (ADM) | ◐ | ✓ | ✓ | ✓ | − | ◐ |
| Ingredion Incorporated | − | − | ◐ | ◐ | ◐ | ◐ |
| Kerry Group plc | ◐ | − | ◐ | ◐ | ✓ | − |
| DSM Nutritional Products | − | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE86
2Cargill80
3Incorporated75
4Archer Daniels Midland Company (ADM)68
5DuPont de Nemours Inc.67
6Ingredion Incorporated62
7Kerry Group plc52
8DSM Nutritional Products45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SECargill
Challenger3
Strong scale, closing on the leaders.
IncorporatedDuPont de Nemours Inc.Archer Daniels Midland Company (ADM)
Contender1
Focused players with pockets of strength.
Ingredion Incorporated
Niche2
Specialists in a single segment or region.
Kerry Group plcDSM Nutritional Products
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Ingredient Type in North America, then scale across Heart Healthy Ingredients Market — a $62M beachhead inside a $903M market.
Beachhead (SOM)$62Mobtainable near-term
Serviceable (SAM)$368Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Omega-3 Fatty Acids
Best fit — highest urgency & budget in Ingredient Type.
Economic buyer78 fit
Plant Sterols and Stanols
Strong fit — clear ROI and a fast path to value.
End user66 fit
Soluble Fiber
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Ingredient Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Source & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Ingredient Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Heart Healthy Ingredients Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified22%
Evaluation14%
Closed-won8%
$16.2KCAC
$95KLTV
5.8:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Heart Healthy Ingredients Market is a durable-growth opportunity — $2.14B by 2033, compounding at 6.4%.
TAM · 2025$1.30Btoday
TAM · 2033$2.14Bforecast
CAGR6.4%2027–2033
Cumulative$15.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.14BTotal addressable market
SAM$760MServiceable available market
SOM$125MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.4% CAGR
Demand compounds through 2033, outpacing GDP across Ingredient Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Ingredient Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.14BLarge & growingTAM by 2033 at 6.4% CAGR
$760MServiceable nowreachable with today’s model
$125MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.67BBear4.2% CAGR
$2.14BBase6.4% CAGR
$2.74BBull8.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Source optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Heart Healthy Ingredients Market — a $6.56B market by 2033. Plan: grow share from 9.4% to 18.1%.
Market size · 2033$6.56Btotal addressable
Market CAGR5.5%2027–2033
Target share18.1%from 9.4% today
Revenue ambition$1.19Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.4% | 18.1% | At risk |
| Revenue | $583M | $1.19B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 28.8% | 45.4% | On track |
| Customer retention | 89.8% | 96.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Ingredient Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Source capability
A defensible second engine — invest in Source to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Ingredient Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Source
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $142M capacity & capability investment
- Greenlight bolt-on M&A in Source
- Authorise North America expansion plan
- Fund R&D program for Ingredient Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Heart Healthy Ingredients Market conversation — a $10.1B market you can size, segment and defend in minutes.
Market size · 2033$10.1Btotal opportunity
Growth9.2%CAGR to 2033
Addressable buyers1,115+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Ingredient Type
Goal Grow share in Ingredient Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 4 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
BASF SECargillIncorporatedDuPont de Nemours Inc.Archer Daniels Midland Company (ADM)Ingredion IncorporatedKerry Group plcDSM Nutritional Products+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Heart Healthy Ingredients Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Heart Healthy Ingredients Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Immunoglobulins Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportGrowth Factors (Blood and Tissue) Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBone and Joint Health Supplements Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportAsthma Management Products Market
Market size, share, segmentation and regional forecast.
$869M market · 2025 base year
View reportArthritis Drug Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportArtificial Saliva Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportAscorbic Acid Market
Market size, share, segmentation and regional forecast.
$371M market · 2025 base year
View reportAnti-Obesity Prescription Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportAntithrombotic Drugs Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportAnticoccidial Drugs Market
Market size, share, segmentation and regional forecast.
$661M market · 2025 base year
View reportAntifibrinolytic Drugs Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportMedical Collagen Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.